Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipid Storage Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT01461304
What this trial is testing

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

Who this might be right for
Very Long-chain acylCoA Dehydrogenase (VLCAD) DeficiencyCarnitine Palmitoyltransferase Deficiencies (CPT1, CPT2)Mitochondrial Trifunctional Protein Deficiency+5 more
Jerry Vockley, MD, PhD
Not applicableEnded earlyNCT02830763
What this trial is testing

Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M

Who this might be right for
Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)Neutral Lipid Storage Disease With Myopathy (NLSD-M)
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2
Early research (Phase 1)Study completedNCT00357786
What this trial is testing

An Open-Label Maintenance Study of the Enzyme Replacement Therapy Replagal in Patients With Fabry Disease

Who this might be right for
Fabry Disease
National Institute of Neurological Disorders and Stroke (NINDS) 3
Not applicableStudy completedNCT00233870
What this trial is testing

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 405
Not applicableStudy completedNCT06154408
What this trial is testing

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

Who this might be right for
LDL HyperlipoproteinemiaLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaTriglyceride Storage Type I or II Disease
S.LAB (SOLOWAYS) 102
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Early research (Phase 1)Study completedNCT00316498
What this trial is testing

Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease

Who this might be right for
Niemann Pick Diseases
National Eye Institute (NEI) 30
Not applicableUnknownNCT06169358
What this trial is testing

Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy

Who this might be right for
Hypertrophic CardiomyopathyLeft Ventricular HypertrophyFabry Disease
Qilu Hospital of Shandong University 627
Not applicableUnknownNCT02851550
What this trial is testing

Assessement of the Prevalence of Lysosomal Acid Lipase Deficiency in Liver Post-transplant Patients

Who this might be right for
Liver Post-transplant Patients
Hospices Civils de Lyon 100
Not applicableStudy completedNCT01165697
What this trial is testing

Establishment of Biomarkers for Fabry Disease

Who this might be right for
Fabry Disease
Ohio State University 4
Testing effectiveness (Phase 2)Study completedNCT00391625
What this trial is testing

Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)

Who this might be right for
Gaucher Disease
Shire 10
Not applicableStudy completedNCT01358474
What this trial is testing

Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism

Who this might be right for
Parkinson DiseaseGaucher DiseaseIdiopathic Rapid Eye Movement Sleep Disorder
University of Minnesota 56
Not applicableUnknownNCT01442350
What this trial is testing

Myocardial Affectation in Patients With Fabry Disease Without Phenotypic Manifestation. Diagnostic Value of Biomarkers

Who this might be right for
Fabry Disease, Cardiac VariantRight Ventricular Hypertrophy
Francisco Marín Ortuño 120
Testing effectiveness (Phase 2)Study completedNCT00214500
What this trial is testing

AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT01801709
What this trial is testing

Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy

Who this might be right for
Metachromatic Leukodystrophy
Institut National de la Santé Et de la Recherche Médicale, France 5
Testing effectiveness (Phase 2)Study completedNCT06949358
What this trial is testing

Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France

Who this might be right for
Acid Sphingomyelinase Deficiency
Sanofi 3
Large-scale testing (Phase 3)Study completedNCT01074944
What this trial is testing

Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 170
Testing effectiveness (Phase 2)Ended earlyNCT03454893
What this trial is testing

Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease

Who this might be right for
Fabry Disease
AVROBIO 15
Testing effectiveness (Phase 2)Study completedNCT00084084
What this trial is testing

Replagal Enzyme Replacement Therapy for Children With Fabry Disease

Who this might be right for
Fabry Disease
Shire 17
Not applicableUnknownNCT03542370
What this trial is testing

Umbrella Review of the DASH Dietary Pattern and Cardiometabolic Risk

Who this might be right for
Cardiovascular Risk FactorCardiovascular DiseasesCoronary Heart Disease+6 more
University of Toronto 1
Next Page